Features

Filter

Current filters:

None

Popular Filters

26 to 49 of 49 results

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

Faster, better, safer: How clinical trials can be transformed by Equivital wearable technology

04-02-2014

A UK-based mobile human monitoring company is making waves in health care as it aims to revolutionize…

BiotechnologyInterviewsPharmaceuticalResearchUK

EXPERT VIEW: Pharmaceutical firms “can’t keep ignoring information risk”

28-01-2014

Knowledge is the lifeblood of the pharmaceutical sector. From raw experimental data to complex chemical…

EuropeInterviewsManagementPharmaceutical

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

Genesis 2013: Secrets of B-MS and AstraZeneca Amylin deal revealed

16-12-2013

Secrets of how Bristol-Myers Squibb and AstraZeneca arranged a behind-the-scenes deal to buy Amylin were…

AmylinAstraZenecaBristol-Myers SquibbDiabetesInterviewsLegalMergers & AcquisitionsPharmaceuticalUKUSA

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

16-12-2013

The UK’s brightest bioscience companies met in London for the One Nucleus Genesis 2013 conference on…

BiotechnologyFinancialInterviewsMerck SeronoResearchUK

FT Pharma 2013: Panel discusses diversity needed in high-level positions

FT Pharma 2013: Panel discusses diversity needed in high-level positions

04-12-2013

A Twitter debate was sparked yesterday after the Financial Times Global Pharmaceutical & Biotechnology…

GlobalHealthcareInterviewsPharmaceuticalPolitics

FT Pharma 2013: NICE chair David Haslam says “I want as many yeses as possible”

FT Pharma 2013: NICE chair David Haslam says “I want as many yeses as possible”

04-12-2013

The chair of the UK’s regulatory body the National Institute for Health and Care Excellence shared…

InterviewsPharmaceuticalRegulationUK

FT Pharma 2013: Bayer chairman Marijn Dekkers says “patients don’t appreciate us”

FT Pharma 2013: Bayer chairman Marijn Dekkers says “patients don’t appreciate us”

03-12-2013

Most patients don’t appreciate the pharma companies that save their lives, Bayer chairman Marijn Dekkers…

BayerHealthcareInterviewsPharmaceuticalPoliticsUSA

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

EXPERT VIEW: Talent acquisition at the heart of M&A

EXPERT VIEW: Talent acquisition at the heart of M&A

22-10-2013

Mergers and acquisitions are common – 111 M&As took place in the UK in the second quarter of 2013 alone…

BoardroomInterviewsMergers & AcquisitionsPharmaceutical

BIA UK BioScience Forum: Accelerating vaccine development

BIA UK BioScience Forum: Accelerating vaccine development

15-10-2013

Recent advances in vaccine development in the UK were heard by interested delegates at the UK BioScience…

BiotechnologyEuropeInterviewsResearchVaccines

BIA UK BioScience Forum: The benefits of the European Unitary Patent

BIA UK BioScience Forum: The benefits of the European Unitary Patent

14-10-2013

Updates on Intellectual Property developments in Europe were heard by delegates at the BIA UK BioScience…

EuropeInterviewsPatentsPharmaceutical

IN FOCUS: Using the body’s own defenses against cancer - Scancell reveals its immunotherapy products

IN FOCUS: Using the body’s own defenses against cancer - Scancell reveals its immunotherapy products

07-10-2013

UK-based cancer therapeutics firm Scancell, developer of novel immunotherapies, gathered its investors…

BiotechnologyEuropeFinancialInterviewsOncologyScancell

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

IN FOCUS: A post-ERS look at Verona Pharma’s respiratory pipeline

20-09-2013

Fresh from their trip to the European Respiratory Society annual congress in Barcelona, Verona Pharma’s…

EuropeInterviewsPharmaceuticalResearchRespiratory and Pulmonary

EXPERT VIEW: AstraZeneca warns of

EXPERT VIEW: AstraZeneca warns of "significant risk to health" from antimicrobial resistance

13-09-2013

One of the UK's leading pharma companies has expressed its support for the Department of Health's five…

AstraZenecaEuropeHealthcareInterviewsPharmaceutical

EXPERT VIEW: What does the future hold for clinical trials data and pharmacovigilance in Europe?

EXPERT VIEW: What does the future hold for clinical trials data and pharmacovigilance in Europe?

12-09-2013

Europe is leading the way when it comes to transparency in clinical trials data, says regulatory lawyer…

EuropeInterviewsPharmaceutical

EXPERT VIEW: Patent attorney Gareth Williams speaks about the potential issues facing the pharmaceutical industry

EXPERT VIEW: Patent attorney Gareth Williams speaks about the potential issues facing the pharmaceutical industry

18-07-2013

As patent expiration becomes an increasing hurdle for pharma companies worldwide, The Pharma Letter spoke…

InterviewsPharmaceutical

26 to 49 of 49 results

Back to top